Skip to main content
. 2021 Jan 27;126(6):804–817. doi: 10.1007/s11547-020-01331-7

Table 3.

Univariate analysis for technical outcomes (mTICI 2b-3 and Extracranial ICA Recanalization)

Variable mTICI 0-2a
(n=52)
mTICI 2b-3
(n=175)
p-value
Age-years, mean (SD) 65.5 (11.3) 66.1 (13.4) 0.748
Gender, n (%)

Male

Female

36 (23.4)

16 (21.9)

118 (76.2)

57 (78.1)

0.867
Baseline NIHSS, median (IQR) 16.0 (12.0–20.8) 16.0 (11.0–20.0) 0.719
IV-FL, n (%)

Yes

No

32 (21.9)

20 (24.7)

114 (78.1)

61 (75.3)

0.625
Baseline ASPECTS, median (IQR) 8.5 (7.8–9.0) 9.0 (8.0–10.0) 0.114
Intracranial Lesion site, n (%)

ICA

ICA T-type

M1

M2 or distal

Hemodynamic TLs

4 (26.7)

12 (28.6)

16 (16.5)

12 (29.3)

8 (25.0)

11 (73.3)

30 (71.4)

81 (83.5)

29 (70.7)

24 (75.0)

0.332
Extracranial Lesion
1. Etiology, n (%)

Plaque

Dissection

37 (21.5)

15 (27.3)

135 (78.5)

40 (72.7)

0.718
2. Type, n (%)

Occlusion

Subocclusion or Stenosis

35 (26.9)

17 (17.5)

95 (73.1)

80 (82.5)

0.111
Collateral Flow, n (%)
Good 21 (21.2) 78 (78.8) 0.361
Moderate 15 (20.0) 60 (80.0)
Poor 16 (30.2) 37 (69.8)
Anesthesia, n (%)

General Anesthesia

Conscious Sedation

26 (25.0)

26 (21.1)

78 (75.0)

97 (78.9)

0.528
Intracranial Thrombectomy, n (%)
TA 21 (19.4) 87 (80.6) 0.574
SCoT 16 (23.2) 53 (76.8)
eCAS, n (%)

Yes

No

18 (13.6)

34 (35.8)

114 (86.4)

61 (64.2)

0.0001
Order of treatment, n (%)

Anterograde approach

Retrograde approach

8 (11.9)

10 (15.4)

59 (88.1)

55 (84.6)

0.619
Timing-minutes, mean (SD)

OTG

GTR

261.5 (105.0)

87.0 (42.3)

251.3 (122.1)

73.3 (43.2)

0.572

0.064

Complications, n (%)

Yes

No

14 (36.8)

38 (20.1)

24 (63.2)

151 (79.9)

0.034
Extracranial ICA Recanalization, n (%)

Yes

No

30 (15.2)

22 (73.3)

167 (84.8)

8 (26.7)

< 0.00001
Variable No Extracranial ICA Recanalization
(n=30)
Extracranial ICA Recanalization
(n=197)
p-value
Age-years, mean (SD) 65.8 (13.4) 65.8 (12.8) 0.998
Gender, n (%)

Male

Female

20 (13.0)

10 (13.7)

134 (87.0)

63 (86.3)

1
Baseline NIHSS, median (IQR) 15.5 (10.8-21.0) 16.0 (11.0-20.0) 0.803
IV-FL, n (%)

Yes

No

16 (11.0)

14 (17.3)

130 (89.0)

67 (82.7)

0.220
Extracranial Lesion
1. Etiology, n (%)

Plaque

Dissection

20 (11.6)

10 (18.2)

152 (88.4)

45 (81.8)

0.252
2. Type, n (%)

Occlusion

Subocclusion or Stenosis

23 (17.7)

7 (7.2)

107 (82.3)

90 (92.8)

0.028
eCAS, n (%)

Yes

No

6 (4.5)

24 (25.3)

126 (95.5)

71 (74.7)

<0.00001
Antiplatelet Therapy
1. All, n (%)

Yes

No

10 (7.7)

20 (20.6)

120 (92.3)

77 (79.4)

0.006
2. Class, n (%)

ASA

P2Y12 Inhibitors

GpIIb/IIIa Inhibitors

6 (9.5)

0 (0)

4 (6.8)

57 (90.5)

8 (100)

55 (93.2)

0.810

1

Order of treatment, n (%)

Anterograde approach

Retrograde approach

4 (6.0)

2 (3.1)

63 (94.0)

63 (96.9)

1
Timing-minutes, mean (SD)

OTG

GTR

223.7 (89.4)

86.4 (36.1)

257.7 (121.4)

74.9 (43.9)

0.091

0.198

Complications, n (%)

Yes

No

2 (5.3)

28 (14.8)

36 (94.7)

161 (85.2)

0.186